blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2717902

EP2717902 - USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.11.2018
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  22.12.2017
FormerGrant of patent is intended
Status updated on  18.12.2017
FormerExamination is in progress
Status updated on  04.10.2017
FormerGrant of patent is intended
Status updated on  08.06.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): MK		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
Phasebio Pharmaceuticals, Inc.
One Great Valley Parkway Suite 30
Malvern, Pennsylvania 19355 / US
[2018/04]
Former [2014/16]For all designated states
Phasebio Pharmaceuticals, Inc.
One Great Valley Parkway Suite 30
Malvern, Pennsylvania 19355 / US
Inventor(s)01 / GEORGOPOULOS, Lynne, M.
c/o Phasebio Pharmaceuticals Inc
One Great Valley Parkway
Suite 30
Malvern, PA 19355 / US
02 / ARNOLD, Susan
c/o Phasebio Pharmaceuticals Inc
One Great Valley Parkway
Suite 30
Malvern, PA 19355 / US
 [2014/16]
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[N/P]
Former [2018/04]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Former [2014/16]Stephen, Robert John
Olswang LLP 90 High Holborn
London WC1V 6XX / GB
Application number, filing date12796397.306.06.2012
[2018/04]
WO2012US41092
Priority number, dateUS201161493845P06.06.2011         Original published format: US 201161493845 P
[2014/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012170524
Date:13.12.2012
Language:EN
[2012/50]
Type: A1 Application with search report 
No.:EP2717902
Date:16.04.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 13.12.2012 takes the place of the publication of the European patent application.
[2014/16]
Type: B1 Patent specification 
No.:EP2717902
Date:24.01.2018
Language:EN
[2018/04]
Search report(s)International search report - published on:US13.12.2012
(Supplementary) European search report - dispatched on:EP11.12.2014
ClassificationIPC:A61K38/17, A61P31/10, C07K14/47
[2014/16]
CPC:
A61K38/2278 (EP,US); A61K31/165 (EP,US); A61K31/403 (EP,US);
A61K31/4045 (EP,US); A61K31/4418 (EP,US); A61K38/39 (EP,US);
A61K45/06 (EP,US); A61P31/10 (EP); A61P9/12 (EP);
C07K14/57563 (EP,US); C07K14/78 (EP,US); A61K38/00 (EP,US);
C07K2319/00 (EP,US) (-)
C-Set:
A61K31/403, A61K2300/00 (EP,US);
A61K38/2278, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/16]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERWENDUNG MODIFIZIERTER VASOAKTIVER DARMPEPTIDE BEI DER BEHANDLUNG VON BLUTHOCHDRUCK[2014/16]
English:USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION[2014/16]
French:UTILISATION DE PEPTIDES INTESTINAUX VASOACTIFS (PIV) MODIFIÉS POUR TRAITER L'HYPERTENSION[2014/16]
Entry into regional phase03.01.2014National basic fee paid 
03.01.2014Search fee paid 
03.01.2014Designation fee(s) paid 
03.01.2014Examination fee paid 
Examination procedure03.01.2014Examination requested  [2014/16]
28.08.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
05.11.2015Amendment by applicant (claims and/or description)
21.03.2016Despatch of a communication from the examining division (Time limit: M04)
25.07.2016Reply to a communication from the examining division
09.06.2017Communication of intention to grant the patent
29.09.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
29.09.2017Fee for grant paid
29.09.2017Fee for publishing/printing paid
18.12.2017Information about intention to grant a patent
18.12.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.03.2016
Opposition(s)25.10.2018No opposition filed within time limit [2019/01]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
05.11.2015Request for further processing filed
05.11.2015Full payment received (date of receipt of payment)
Request granted
17.11.2015Decision despatched
Fees paidRenewal fee
30.06.2014Renewal fee patent year 03
29.06.2015Renewal fee patent year 04
27.06.2016Renewal fee patent year 05
27.06.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.06.2012
AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
MK24.01.2018
PL24.01.2018
PT24.01.2018
RO24.01.2018
RS24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
TR24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
IE06.06.2018
LU06.06.2018
MT06.06.2018
[2020/31]
Former [2020/27]HU06.06.2012
AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
PL24.01.2018
PT24.01.2018
RO24.01.2018
RS24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
TR24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
IE06.06.2018
LU06.06.2018
MT06.06.2018
Former [2020/16]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
TR24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
IE06.06.2018
LU06.06.2018
MT06.06.2018
Former [2020/08]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
IE06.06.2018
LU06.06.2018
MT06.06.2018
Former [2019/19]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
IE06.06.2018
LU06.06.2018
Former [2019/17]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
LU06.06.2018
Former [2019/15]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
MC24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
Former [2019/13]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SI24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/52]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SK24.01.2018
SM24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/51]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
DK24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SK24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/50]AL24.01.2018
AT24.01.2018
CY24.01.2018
CZ24.01.2018
EE24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
PL24.01.2018
RO24.01.2018
RS24.01.2018
SK24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/46]AL24.01.2018
AT24.01.2018
CY24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
PL24.01.2018
RS24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/40]AT24.01.2018
CY24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
PL24.01.2018
RS24.01.2018
BG24.04.2018
GR25.04.2018
IS24.05.2018
Former [2018/39]AT24.01.2018
CY24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
LV24.01.2018
PL24.01.2018
RS24.01.2018
GR25.04.2018
IS24.05.2018
Former [2018/37]CY24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
PL24.01.2018
GR25.04.2018
Former [2018/36]CY24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
PL24.01.2018
Former [2018/35]CY24.01.2018
FI24.01.2018
HR24.01.2018
LT24.01.2018
Documents cited:Search[Y] WO2011020091  (PHASEBIO PHARMACEUTICALS INC et al.) [Y] 1-9,11-17 * abstract * * paragraph [0002]; figures 1-15; claims 1-43 * * paragraph [0007] * * paragraph [0014] * * paragraph [0038] * * paragraph [0075] * * paragraph [0109] * * paragraph [0094] * * paragraph [0099] - paragraph [0102] *
 [Y] US2008221041  (BLOCK LUTZ-HENNING et al.) [Y] 1-9,11-17 * abstract * * page 3, column l, paragraph 1 - paragraph 5 * * paragraph [0033] * * paragraph [0062] *
 [Y]   KAREN A. DUGGAN ET AL: "Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 358, no. 1, 1 September 1998 (1998-09-01), pages 25 - 30, XP055156403, ISSN: 0014-2999, DOI: 10.1016/S0014-2999(98)00583-4 [Y] 1-9,11-17 * abstract *

DOI:   http://dx.doi.org/10.1016/S0014-2999(98)00583-4
by applicant  EGAN ET AL., JAMA, vol. 303, no. 20, 2010, pages 2043 - 2050
   POZO D ET AL., PEPTIDES, vol. 28, no. 9, 2007, pages 1833 - 1846
   DOMSCHKE ET AL., GUT, vol. 19, 1978, pages 1049 - 53
   BURHOL ET AL., SCAND J GASTROENT, vol. 13, 1978, pages 807 - 813
   SAID ET AL., CIRCULATION, vol. 115, 2007, pages 1260 - 8
   CARRETERO ET AL., CIRCULATION, vol. 101, 2000, pages 329 - 35
   MORI ET AL., JPN HEART J., vol. 34, 1993, pages 785 - 94
   ONYUKSEL ET AL., PEPTIDES, vol. 27, 2006, pages 2271 - 5
   ONUNE ET AL., EUR. J. PHARM. BIOPHARM., 2009
   DELGADO ET AL., PHARMACOL. REVIEWS, vol. 56, no. 2, 2004, pages 249 - 290
   TATUSOVA ET AL., FEMS MICROBIOL LETT., vol. 174, 1999, pages 247 - 250
   CLIFTON: "Methods in Molecular Biology", vol. 3, 1985, HUMANA PRESS, article "New Protein Techniques"
   LUNDBLAD: "Techniques in Protein Modification", 1995, CRC PRESS
   NILSSON ET AL., ANN REV BIOPHYS BIO STRUCTURE, vol. 34, 2005, pages 91 - 118
   GREG T. HERMANSON: "Bioconjugate Techniques", 1995, ACADEMIC PRESS, INC.
   SIMONCSITS ET AL., EUR. J. BIOCHEM., vol. 178, no. 2, 1988, pages 343 - 350
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.